Literature DB >> 23573303

Identification of CD68(+) neutrophil granulocytes in in vitro model of acute inflammation and inflammatory bowel disease.

Ahmad Amanzada1, Ihtzaz Ahmed Malik, Martina Blaschke, Sajjad Khan, Hazir Rahman, Giuliano Ramadori, Federico Moriconi.   

Abstract

CD-68 is widely regarded as a selective marker for human monocytes and macrophages and is commonly used in human pathology studies. The purpose of this study was to investigate the expression of CD-68 in human peripheral blood mononuclear cells (PBMCs), neutrophil granulocytes (NGs) and in inflamed intestinal tissue samples for comparison. PBMCs and NGs were isolated from heparinized human blood samples. Intestinal biopsies were obtained during routine endoscopic procedures from patients with inflammatory bowel disease (IBD), e.g. ulcerative colitis and Crohn's disease. Gene and protein expression was analyzed by real-time RT-PCR, Western blot and immunohistochemistry. Both PBMCs and NGs preparations contained cells that were positive for CD-68 and either neutrophil elastase (NE), or myeloperoxidase (MPO). CD-68(+)/NE(-)/MPO(-) cells were regarded as monocytes. CD-68 mRNA expression was detected in PBMCs and NGs preparations. With Western blot and by performing immunoprecipitation of cell lysate, we could clearly detect CD-68 in NGs, U-937, THP-1, Hep-G2, Jurkat cells and PBMCs. Identification of inflammatory cells in acutely inflamed colonic mucosa obtained from patients with IBD revealed a strong accumulation of CD-68(+)/MPO(+) cells compared to normal colonic mucosa. The uptake of the marker by phagocytosis was excluded by performing a double staining with CD-163/NE and CD-163/MPO in PBMCs, NGs cultures and in inflamed colonic mucosa. These results identify CD-68(+) NGs in peripheral blood and inflamed colonic mucosa. CD-68 is not only a marker for the macrophages-monocytes but also for NGs.

Entities:  

Keywords:  CD-68; inflammatory bowel disease; monocytes; neutrophil granulocytes; peripheral blood mononuclear cells

Mesh:

Substances:

Year:  2013        PMID: 23573303      PMCID: PMC3606846     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII).

Authors:  T Häkkinen; K Karkola; S Ylä-Herttuala
Journal:  Virchows Arch       Date:  2000-10       Impact factor: 4.064

2.  KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections.

Authors:  K A Pulford; E M Rigney; K J Micklem; M Jones; W P Stross; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

3.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

4.  Ki-M7 monoclonal antibody specific for myelomonocytic cell lineage and macrophages in human.

Authors:  H Kreipe; H J Radzun; M R Parwaresch; A Haislip; M L Hansmann
Journal:  J Histochem Cytochem       Date:  1987-10       Impact factor: 2.479

5.  Monocyte/macrophage-reactive monoclonal antibody Ki-M6 recognizes an intracytoplasmic antigen.

Authors:  M R Parwaresch; H J Radzun; H Kreipe; M L Hansmann; J Barth
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

6.  Expressions of P53 and CD68 in mouse liver with Schistosoma mansoni infection and the protective role of silymarin.

Authors:  Ehab Tousson; Doha M Beltagy; Maha Abo Gazia; Bahija Al-Behbehani
Journal:  Toxicol Ind Health       Date:  2012-04-16       Impact factor: 2.273

7.  A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies.

Authors:  K Micklem; E Rigney; J Cordell; D Simmons; P Stross; H Turley; B Seed; D Mason
Journal:  Br J Haematol       Date:  1989-09       Impact factor: 6.998

8.  Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.

Authors:  E Kunisch; R Fuhrmann; A Roth; R Winter; W Lungershausen; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

9.  Morphological characterisation of Crohn's disease fistulae.

Authors:  F Bataille; F Klebl; P Rümmele; J Schroeder; S Farkas; P-J Wild; A Fürst; F Hofstädter; J Schölmerich; H Herfarth; G Rogler
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

10.  Monoclonal antibody (Y1/82A) with specificity towards peripheral blood monocytes and tissue macrophages.

Authors:  F R Davey; J L Cordell; W N Erber; K A Pulford; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

View more
  19 in total

1.  Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases.

Authors:  Sebastian Hoefert; Inge Schmitz; Frank Weichert; Marcel Gaspar; Harald Eufinger
Journal:  Clin Oral Investig       Date:  2014-06-24       Impact factor: 3.573

2.  Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice.

Authors:  Alvaro A Ordonez; Supriya Pokkali; Vincent P DeMarco; Mariah Klunk; Ronnie C Mease; Catherine A Foss; Martin G Pomper; Sanjay K Jain
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

3.  Noncanonical Mechanisms for Direct Bone Marrow Generating Ang II (Angiotensin II) Predominate in CD68 Positive Myeloid Lineage Cells.

Authors:  Tomohisa Yamashita; Sarfaraz Ahmad; Kendra N Wright; Drew J Roberts; Jessica L VonCannon; Hao Wang; Leanne Groban; Louis J Dell'Italia; Carlos M Ferrario
Journal:  Hypertension       Date:  2019-12-09       Impact factor: 10.190

4.  CD68/macrosialin: not just a histochemical marker.

Authors:  Dimitry A Chistiakov; Murry C Killingsworth; Veronika A Myasoedova; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Lab Invest       Date:  2016-11-21       Impact factor: 5.662

5.  Development of a 2-dimensional atlas of the human kidney with imaging mass cytometry.

Authors:  Nikhil Singh; Zachary M Avigan; Judith A Kliegel; Brian M Shuch; Ruth R Montgomery; Gilbert W Moeckel; Lloyd G Cantley
Journal:  JCI Insight       Date:  2019-06-20

Review 6.  Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.

Authors:  Kira G Hartman; James D Bortner; Gary W Falk; Gregory G Ginsberg; Nirag Jhala; Jian Yu; Martín G Martín; Anil K Rustgi; John P Lynch
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-29

7.  Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner.

Authors:  Tobias Bald; Jennifer Landsberg; Philipp Jansen; Evelyn Gaffal; Thomas Tüting
Journal:  Oncoimmunology       Date:  2015-09-01       Impact factor: 8.110

8.  The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment.

Authors:  José M García-Heredia; Amancio Carnero
Journal:  Oncotarget       Date:  2017-10-06

9.  Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo.

Authors:  Asif J Iqbal; Eileen McNeill; Theodore S Kapellos; Daniel Regan-Komito; Sophie Norman; Sarah Burd; Nicola Smart; Daniel E W Machemer; Elena Stylianou; Helen McShane; Keith M Channon; Ajay Chawla; David R Greaves
Journal:  Blood       Date:  2014-07-16       Impact factor: 25.476

Review 10.  Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases.

Authors:  Kallirroi S Kyriakidi; Vasileios E Tsianos; Evaggelos Karvounis; Dimitrios K Christodoulou; Konstantinos H Katsanos; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2016-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.